August 9, 2017

MTPA Perspective Regarding Medicare Coverage

As an FDA-approved therapy, RADICAVATM (edaravone) will have coverage under Medicare policy. However, each local administrator may choose to establish independent criteria for coverage. Claims are processed through nine local Medicare Administrative Contractors (MACs) responsible for 12 geographical jurisdictions.

For specifics regarding Medicare coding and coverage, Health Care Providers (HCPs) should contact their local MAC carrier.

Searchlight SupportTM will help verify patients’ Medicare Part B Supplemental insurance coverage as well as Medicare Part D coverage for home infusion. Patients and providers should call Searchlight Support at 1-844-SRCHLGT (1-844-772-4548) for additional information.